Picture of Benchmark Holdings logo

BMK — Benchmark Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesAdventurousSmall CapNeutral

Notice of Q1 Results

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230214:nRSN8935Pa&default-theme=true

RNS Number : 8935P  Benchmark Holdings PLC  14 February 2023

14 February 2023

 

Benchmark Holdings plc

 

("Benchmark", the "Company" or the "Group")

 

Notice of Q1 Results

 

Presentation for analysts and institutional investors

 

Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture
biotechnology business, will announce its Q1 results, for the three month
period ended 31 December 2022, on Tuesday 28 February 2023.

 

Presentation for analysts and investors at 9 am CET

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host an in-person presentation for analysts and institutional
investors on the day at 9.00 am CET/8.00 am UK time in Oslo, Norway. The
presentation will take place at Hotel Continental, Stortingsgata 24/26, 0117
Oslo.

 

A live webcast of the presentation is available for analysts and investors to
join remotely at the following link:
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230228_7
(https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230228_7)

 

For further details, and to register your interest, please
contact benchmark@mhpgroup.com (mailto:benchmark@mhpgroup.com) .

 

Equity Development webcast on Wednesday 1 March at 12 pm UK time

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a second webcast for retail investors and wealth managers on
Wednesday 1 March at 13.00 pm CET/12.00 pm UK time. The webcast is open to all
existing and potential shareholders.

 

To register please visit:
https://www.equitydevelopment.co.uk/news-and-events/benchmark-q1results-presentation-1march2023
(https://protect-eu.mimecast.com/s/oEk3Cqjwof28oM2CZsi5N?domain=equitydevelopment.co.uk)

 

A recording of the presentation will be available after the event on the
Equity Development website
(https://www.equitydevelopment.co.uk/research/tag/benchmark-holdings) .

 

 

  Enquiries

 For further information, please contact:
 Benchmark Holdings plc                           Tel:  0114 240 9939
 Trond Williksen, CEO
 Septima Maguire, CFO
 Ivonne Cantu, Investor Relations

 Numis (Broker and NOMAD)                         Tel:  020 7260 1000
 James Black, Freddie Barnfield, Duncan Monteith

 MHP                                              Tel:  020 3128 8004
 Katie Hunt, Reg Hoare, Veronica Farah            benchmark@mhpgroup.com (mailto:benchmark@mhpgroup.com)

 Equity Development                               Tel:  020 7065 2692

 Hannah Crowe

 

 

About Benchmark

Benchmark is a leading aquaculture biotechnology company. Benchmark's mission
is to enable aquaculture producers to improve their sustainability and
profitability.

We bring together biology and technology to develop innovative products and
solutions which improve yield, quality and animal health and welfare for our
customers. We do this by improving the genetic make-up, health and nutrition
of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon
eggs, live feed (Artemia), specialist diets and probiotics and sea lice
treatments. Find out more at www.benchmarkplc.com
(http://www.benchmarkplc.com/) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORGPUCWPUPWGGC

Recent news on Benchmark Holdings

See all news